CAMP4 Analyst Highlights Rare Disease Platform Potential

BenzingaNov 5 15:06 ET

Camp4 Gains After Earning Bullish Views on Street

Seeking AlphaNov 5 13:56 ET

CAMP4 Therapeutics Shares Are Trading Higher After Multiple Firms Initiated Coverage on the Stock With Overweight Ratings.

BenzingaNov 5 11:03 ET

Leerink Partners Initiates Camp4 Therapeutics(CAMP.US) With Buy Rating, Announces Target Price $17

Moomoo NewsNov 5 06:36 ET · Ratings

William Blair Initiates Camp4 Therapeutics(CAMP.US) With Buy Rating

Moomoo NewsNov 5 06:36 ET · Ratings

Camp4 Therapeutics Initiated With an Outperform at Leerink

TipRanksNov 5 06:20 ET · Ratings